UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer

Health technology assessment (Winchester, England), 2016-05, Vol.20 (40), p.1-146

2016

Link zum Volltext

Verfügbarkeit prüfen

PD-1 blockade in advanced NSCLC: A focus on pembrolizumab

Cancer treatment reviews, 2018-01, Vol.62, p.39-49

2018

Link zum Volltext

Verfügbarkeit prüfen

DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma

PloS one, 2011-06, Vol.6 (6), p.e21443-e21443

2011

Link zum Volltext

Verfügbarkeit prüfen

Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC

Nature reviews. Clinical oncology, 2019-06, Vol.16 (6), p.341-355

2019

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 as a biomarker of response to immune-checkpoint inhibitors

Nature reviews. Clinical oncology, 2021-06, Vol.18 (6), p.345-362

2021

Link zum Volltext

Verfügbarkeit prüfen

The PD-L1 Immunohistochemistry Biomarker: Two Steps Forward, One Step Back?

Journal of thoracic oncology, 2018-03, Vol.13 (3), p.291-294

Kerr, Keith M.

2018

Link zum Volltext

Verfügbarkeit prüfen

The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

Journal of thoracic oncology, 2022-03, Vol.17 (3), p.362-387

2022

Link zum Volltext

Verfügbarkeit prüfen

Programmed Death Ligand-1 Immunohistochemistry: Friend or Foe?

Archives of pathology & laboratory medicine (1976), 2016-04, Vol.140 (4), p.326-331

2016

Link zum Volltext

Verfügbarkeit prüfen

Personalized medicine for lung cancer: new challenges for pathology

Histopathology, 2012-03, Vol.60 (4), p.531-546

Kerr, Keith M

2012

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project

Journal of thoracic oncology, 2017-02, Vol.12 (2), p.208-222

2017

Link zum Volltext

Verfügbarkeit prüfen

Non-Small Cell Lung Cancer, PD-L1, and the Pathologist

Archives of pathology & laboratory medicine (1976), 2016-03, Vol.140 (3), p.249-254

2016

Link zum Volltext

Verfügbarkeit prüfen

The evolving landscape of biomarker testing for non-small cell lung cancer in Europe

Lung cancer (Amsterdam, Netherlands), 2021-04, Vol.154, p.161-175

2021

Link zum Volltext

Verfügbarkeit prüfen

The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification

Journal of thoracic oncology, 2015-09, Vol.10 (9), p.1243-1260

2015

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary adenocarcinomas: classification and reporting

Histopathology, 2009-01, Vol.54 (1), p.12-27

Kerr, Keith M

2009

Link zum Volltext

Verfügbarkeit prüfen

Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2017-12, Vol.35 (34), p.3867-3876

2017

Link zum Volltext

Verfügbarkeit prüfen

Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art?

Journal of thoracic oncology, 2015-07, Vol.10 (7), p.985-989

2015

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

Journal of thoracic oncology, 2018-09, Vol.13 (9), p.1302-1311

2018

Link zum Volltext

Verfügbarkeit prüfen

British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma

Thorax, 2018-03, Vol.73 (Suppl 1), p.i1

2018

Link zum Volltext

Verfügbarkeit prüfen

Improving practice in PD-L1 testing of non-small cell lung cancer in the UK: current problems and potential solutions

Journal of clinical pathology, 2024-02, Vol.77 (2), p.135

2024

Link zum Volltext

Verfügbarkeit prüfen

Cytology for PD-L1 testing: A systematic review

Lung cancer (Amsterdam, Netherlands), 2020-03, Vol.141, p.101-106

2020

Link zum Volltext

Verfügbarkeit prüfen

A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

Journal of thoracic oncology, 2020-10, Vol.15 (10), p.1599-1610

2020

Link zum Volltext

Verfügbarkeit prüfen

Association between gene expression profiles and clinical outcome of pemetrexed-based treatment in patients with advanced non-squamous non-small cell lung cancer: exploratory results from a phase II study

PloS one, 2014-09, Vol.9 (9), p.e107455

2014

Link zum Volltext

Verfügbarkeit prüfen

The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

Journal of thoracic oncology, 2020-09, Vol.15 (9), p.1409-1424

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 438

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(355)
Mit Volltextzugriff
(398)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(433)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer

PD-1 blockade in advanced NSCLC: A focus on pembrolizumab

DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma

Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC

PD-L1 as a biomarker of response to immune-checkpoint inhibitors

The PD-L1 Immunohistochemistry Biomarker: Two Steps Forward, One Step Back?

The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

Programmed Death Ligand-1 Immunohistochemistry: Friend or Foe?

Personalized medicine for lung cancer: new challenges for pathology

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project

Non-Small Cell Lung Cancer, PD-L1, and the Pathologist

The evolving landscape of biomarker testing for non-small cell lung cancer in Europe

The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification

Pulmonary adenocarcinomas: classification and reporting

Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer

Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art?

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma

Improving practice in PD-L1 testing of non-small cell lung cancer in the UK: current problems and potential solutions

Cytology for PD-L1 testing: A systematic review

A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

Association between gene expression profiles and clinical outcome of pemetrexed-based treatment in patients with advanced non-squamous non-small cell lung cancer: exploratory results from a phase II study

PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

Suchergebnisse filtern